跳转至内容
Merck
CN

EHU029301

MISSION® esiRNA

targeting human OIP5

登录 查看组织和合同定价。

选择尺寸

关于此项目

NACRES:
NA.51
UNSPSC Code:
41105324

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

MISSION® esiRNA, targeting human OIP5

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CGCACAATCGCTTAAAATCACTAATGAAGATTCTGAGTGAAGTGACTCCTGACCAGTCCAAGCCAGAAAACTGATCCTGTACCAAAGCTTGAGTGTCAGGTTCAGGCTTTATTGCTGTCTTCAACAACAGGTGCTGCTTAGTCATTTCTTGAAAAAGATTGGCTTCAAGAATGGAGGGGAAATGCAGTTTCTATTTACCTTTAGGCTGATTTTCCAAATTATTTGTGAAGCTGTTTTTAGAAGATGAGAGACTAAGGATTCTTCTCTTTTATAGCTATTTGCCTTAAGAACTTACTTTAGATTCTTATTGAATTCATAATACTTATCTCTGAAAATGTCTTTGACTGTAAATTTAGGAATTAAGATGCAGAGTCCCATGTGTCCTCTGATCTAAAGTTGCATGGTTGGTCTGAAAA

Ensembl | human accession no.

ENSG00000104147

NCBI accession no.

NM_007280

shipped in

ambient

storage temp.

−20°C

Quality Level

100

Gene Information

human ... OIP5(11339), OIP5(11339)

相关类别

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
JRR

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Ke Liu et al.
Molecular oncology, 14(10), 2678-2695 (2020-07-08)
The prognosis for osteosarcoma (OS) is dismal due to the aggressive tumor growth and high incidence of metastasis. The long noncoding RNA human homeobox A transcript at the distal tip (HOTTIP) and the transcription factor forkhead box C1 (FOXC1) present
Dorival Mendes Rodrigues-Junior et al.
Journal of molecular neuroscience : MN, 66(3), 383-389 (2018-10-05)
Glioblastoma (GBM) is an incurable disease ranked among the deadliest solid cancers worldwide. A better understanding on the molecular aspects of this malignancy could contribute to the development of new treatment strategies and help to improve survival rates. Previously, our

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持